Epidemiologic studies of environmental exposures in Parkinson's disease
Introduction
Parkinson's disease (PD) is the most common cause of the parkinsonian syndrome and the most frequent neurodegenerative disease after Alzheimer's disease [1]. PD is the consequence of the degeneration of dopaminergic neurons in the substantia nigra. The pathological hallmark of PD is the presence of intracytoplasmic inclusions, known as Lewy bodies in these neurons. Because PD diagnosis is only based on the clinical examination and its cardinal signs can be observed in other, albeit less frequent, conditions, there is a risk of diagnostic misclassification. In a recent autopsy study, 10% of PD patients referred to autopsy in a movement disorders referral center did not have PD after examination of their brain [2]. It is also recognized that the different diagnostic criteria often used in the context of epidemiologic studies can yield different frequency estimates [3], [4].
Incidence studies have provided estimates ranging between 10 and 15 per 100 000 person years [5]; the lifetime risk of PD is of approximately 1.6% [6]. PD is exceptional before 40 years. The incidence of PD increases with age rising from 17.4 per 100 000 person years between 50 to 59 years to 93.1 per 100 000 person years between 70 to 79 years [1]. The incidence of PD is reported to be approximately 1.5 times higher in men than in women [6]; this finding may be related to risk factors more frequently found in men than in women (e.g., occupational risk factors), or to protective factors in women (e.g., hormonal factors). PD prevalence ranges between 100 and 200 per 100 000 persons overall, and between 1.5% and 2.0% after 65 years [7], [8]. Given the ageing of the western populations, an increase in PD prevalence is expected. There is no cure for the disease and only symptomatic treatments are available; any preventive measure would therefore be useful. Although PD treatment has improved in recent years, PD patients have decreased quality of life [9], and face an increased risk of dementia, institutionalization [10] and death [11], [12].
There is important variation in the estimates of PD frequency in different parts of the world. The interpretation of this finding is, however, difficult, because part of this variability is likely to result from differences in the methods used in the studies (e.g., identification of PD patients, diagnostic criteria) [3]. Some conclusions can still be drawn from studies that used similar methods. There is no important difference in PD prevalence among four European countries (France, Italy, Spain, The Netherlands) [7], [8]. The incidence of PD in African Americans and Asian Americans is similar to that in Caucasians [13], [14], [15]. It has also been shown recently that the prevalence of PD in China is similar to that observed in Western countries [16]. On the contrary, a lower prevalence of PD in Africans compared to African Americans has been reported [17], and this has been interpreted as suggestive of an environmental factor.
Studies of temporal trends in the frequency of PD are difficult due to important changes in the diagnosis and treatment of PD in the last decades and few studies are available [18]. An incidence study did not find evidence of temporal trends in Olmsted County (MN, US) during a short period of time (1976–1990) [19]. In Finland, an increase in prevalence of PD was observed between 1971 and 1992, only among men, and it was more pronounced in rural than in urban areas [20]; incidence also increased in men in this time interval, but it decreased in women.
Section snippets
Environmental exposures and Parkinson's disease
PD is considered a multifactorial disease resulting from the effect of environmental factors and genetic susceptibility [21]. In addition to increasing age and male sex, it is likely that several other exposures influence the risk of PD; their identification is complicated by several issues, including small effects, possible interactions with genetic susceptibility, and etiologic heterogeneity [21]. Our review will focus on two environmental exposures that have been quite consistently
Conclusions
We have summarized the results of studies of the relation between PD and some environmental exposures. The pursuit of their identification and understanding the mechanisms that lead to the destruction of dopaminergic neurons are the essential next steps to better understand the etiology of this neurodegenerative condition and, ideally, to develop neuroprotective drugs. In addition, any preventive measure would be useful. Professional pesticide exposure is a preventable exposure for which
References (100)
- et al.
Risk tables for parkinsonism and Parkinson's disease
J Clin Epidemiol
(2002) - et al.
Medical services utilization and prognosis in Parkinson disease: a population-based study
Mayo Clin Proc
(2002) - et al.
Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai
Lancet
(2005) - et al.
Monoamine oxidase and cigarette smoking
Neurotoxicology
(2003) - et al.
Nicotine and nicotinic receptors; relevance to Parkinson's disease
Neurotoxicology
(2002) - et al.
Neurological consequence of industrial exposure to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Lancet
(1985) - et al.
Environmental risk factors and Parkinson's disease: a metaanalysis
Environ Res
(2001) - et al.
Pesticides and Parkinson's disease
Biomed Pharmacother
(1999) - et al.
Toxin-induced models of Parkinson's disease
NeuroRx
(2005) - et al.
Striatal dopaminergic pathways as a target for the insecticides permethrin and chlorpyrifos
Neurotoxicology
(2001)
Environmental risk factors and Parkinson's disease: Selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat
Neurobiol Dis
Pesticides directly accelerate the rate of alpha-synuclein fibril formation: a possible factor in Parkinson's disease
FEBS Lett
Developmental exposure to the pesticides paraquat and maneb and the Parkinson's disease phenotype
Neurotoxicology
The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case–control study and meta-analysis
J Neurol Sci
Incidence and distribution of parkinsonism in Olmsted County, Minnesota, 1976–1990
Neurology
The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service
Brain
A population perspective on diagnostic criteria for Parkinson's disease
Neurology
Influence of strict, intermediate, and broad diagnostic criteria on the age- and sex-specific incidence of Parkinson's disease
Mov Disord
Systematic review of incidence studies of Parkinson's disease
Mov Disord
Prevalence of parkinsonism and Parkinson's disease in Europe: The EUROPARKINSON collaborative study
J Neurol Neurosurg Psychiatry
Prevalence of Parkinson's disease in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group
Neurology
An introduction to the concept of “quality of life in Parkinson's disease”
J Neurol
Survival study of Parkinson Disease in Olmsted County, Minnesota
Arch Neurol
Survival of Parkinson's disease patients in a large prospective cohort of male health professionals
Mov Disord
Epidemiologic observations on Parkinson's disease: incidence and mortality in a prospective study of middle-aged men
Neurology
The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988–1993
Am J Epidemiol
Prevalence of Parkinson's disease in the biracial population of Copiah County, Mississippi
Neurology
Comparison of the prevalence of Parkinson's disease in black populations in the rural United States and in rural Nigeria: door-to-door community studies
Neurology
Two decades of increasing mortality from Parkinson's disease among the US elderly
Arch Neurol
Time trends in the incidence of parkinsonism in Olmsted County, Minnesota
Neurology
Changing epidemiology of Parkinson's disease in southwestern Finland
Neurology
Epidemiologic approaches to the study of Parkinson's disease etiology
Epidemiology
Developmental pesticide models of the Parkinson disease phenotype
Environ Health Perspect
The role of early life environmental risk factors in Parkinson disease: what is the evidence?
Environ Health Perspect
Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity
Arch Neurol
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
Ann Neurol
Cigarette smoking and Parkinson's disease: a case–control study in a population characterized by a high prevalence of pesticide exposure
Mov Disord
Inhibition of monoamine oxidase B in the brains of smokers
Nature
Current evidence for neuroprotective effects of nicotine and caffeine against Parkinson's disease
Drugs Aging
Transdermal nicotine in PD: a randomized, double-blind, placebo-controlled study
Neurology
Differential postmorbidity mortality in observational studies of risk factors for neurologic disorders
Neuroepidemiology
Dopamine-related personality traits in Parkinson's disease
Neurology
Cross-cultural traits for personality of patients with Parkinson's disease in Japan
Am J Med Genet
What is the evidence for a premorbid parkinsonian personality: a systematic review
Mov Disord
Risk and protective factors for Parkinson's disease: a study in Swedish twins
Ann Neurol
Smoking and Parkinson's disease in twins
Neurology
Family-based case–control study of cigarette smoking and Parkinson disease
Neurology
Passive smoking and Parkinson's disease
Neurology
Association of coffee and caffeine intake with the risk of Parkinson disease
JAMA
Prospective study of caffeine consumption and risk of Parkinson's disease in men and women
Ann Neurol
Cited by (98)
Modifiable risk and protective factors in disease development, progression and clinical subtypes of Parkinson's disease: What do prospective studies suggest?
2020, Neurobiology of DiseaseCitation Excerpt :The active metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), whose structure is similar to that of the herbicide paraquat, is known to be involved in the pathogenesis of a subacute form of parkinsonism. In vitro and in vivo studies have shown that some pesticides exert a toxic effect on the dopaminergic pathways (Di Monte et al., 2002; Brown et al., 2006), with recent data suggesting that there may be a gene-based susceptibility to these effects (Gao et al., 2011; Elbaz and Tranchant, 2007). For instance, Elbaz et al. observed that the relationship between pesticide exposure and PD was approximately two times stronger in subjects who were CYP2D6 poor metabolizers than in those who were not (Elbaz et al., 2004).
Analytical tools for evaluation pharmaceutical treatment of neurological diseases - A case study
2020, Procedia ManufacturingProtein carbonylation in dopaminergic cells exposed to rotenone
2019, Toxicology LettersA practical review of gastrointestinal manifestations in Parkinson's disease
2017, Parkinsonism and Related DisordersCitation Excerpt :Alpha-synuclein deposition has been found throughout the enteric nervous system, often described in a rostro-caudal gradient, with a higher burden in the upper gut [25]. However, there has still been no neuronal loss or clear association established between such deposition and symptoms [1,21,26–29]. The central nervous system is also involved with a high level of Lewy bodies found in the dorsal motor nucleus of the vagal nerve (DMV), which has a strong influence on gastrointestinal motility [1,30].
Other neurocognitive disorders in tropical health (amyotrophic lateral sclerosis and parkinson’s disease)
2017, Neuroepidemiology in Tropical Health